SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 118 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $242,000 | -34.2% | 11,468 | -7.2% | 0.03% | -34.7% |
| Q2 2014 | $368,000 | +15.4% | 12,363 | -6.8% | 0.05% | +14.0% |
| Q1 2014 | $319,000 | +17.7% | 13,263 | -0.4% | 0.04% | +16.2% |
| Q4 2013 | $271,000 | -72.3% | 13,318 | -35.8% | 0.04% | -74.8% |
| Q3 2013 | $980,000 | +219.2% | 20,740 | +156.7% | 0.15% | +212.8% |
| Q2 2013 | $307,000 | – | 8,078 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |